HIV infection and osteoporosis
- PMID: 25709813
- PMCID: PMC4325555
- DOI: 10.1038/bonekey.2015.3
HIV infection and osteoporosis
Abstract
In the past two decades, the life expectancy of people living with HIV infection has increased significantly, and osteoporosis has emerged as a significant comorbidity. In addition to traditional risk factors for fracture, specific factors related to HIV infection are also likely to contribute, including antiretroviral therapy. The heterogeneity of the HIV-infected population in terms of age and ethnicity presents many challenges to the prevention and management of bone disease, and further studies are required to establish optimal approaches to risk assessment and treatment.
Conflict of interest statement
The author declares no conflict of interest.
Similar articles
-
HIV infection and bone disease.J Intern Med. 2016 Oct;280(4):350-8. doi: 10.1111/joim.12520. Epub 2016 Jun 6. J Intern Med. 2016. PMID: 27272530 Review.
-
Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis.Osteoporos Int. 2019 May;30(5):1125-1135. doi: 10.1007/s00198-018-4794-0. Epub 2019 Jan 2. Osteoporos Int. 2019. PMID: 30603840
-
People living with HIV and fracture risk.Osteoporos Int. 2020 Sep;31(9):1633-1644. doi: 10.1007/s00198-020-05350-y. Epub 2020 Mar 23. Osteoporos Int. 2020. PMID: 32206852 Review.
-
Understanding mechanisms to promote successful aging in persons living with HIV.Int J Infect Dis. 2018 Jan;66:56-64. doi: 10.1016/j.ijid.2017.11.010. Epub 2017 Nov 14. Int J Infect Dis. 2018. PMID: 29154830 Review.
-
HIV and Bone Disease: A Perspective of the Role of microRNAs in Bone Biology upon HIV Infection.J Osteoporos. 2013;2013:571418. doi: 10.1155/2013/571418. Epub 2013 Oct 27. J Osteoporos. 2013. PMID: 24286015 Free PMC article. Review.
Cited by
-
The Adenosine A2A Receptor Agonist Accelerates Bone Healing and Adjusts Treg/Th17 Cell Balance through Interleukin 6.Biomed Res Int. 2020 Apr 23;2020:2603873. doi: 10.1155/2020/2603873. eCollection 2020. Biomed Res Int. 2020. PMID: 32382539 Free PMC article.
-
Bone fracture among people living with HIV: A systematic review and meta-regression of prevalence, incidence, and risk factors.PLoS One. 2020 Jun 4;15(6):e0233501. doi: 10.1371/journal.pone.0233501. eCollection 2020. PLoS One. 2020. PMID: 32497105 Free PMC article.
-
Ageing with HIV.Healthcare (Basel). 2018 Feb 14;6(1):17. doi: 10.3390/healthcare6010017. Healthcare (Basel). 2018. PMID: 29443936 Free PMC article. Review.
-
The anti-HIV drug abacavir stimulates β-catenin activity in osteoblast lineage cells.JBMR Plus. 2024 Mar 19;8(5):ziae037. doi: 10.1093/jbmrpl/ziae037. eCollection 2024 May. JBMR Plus. 2024. PMID: 38590756 Free PMC article.
-
Patterns of vitamin D, parathyroid hormone and c-terminal telopeptide of collagen type 1 in Caucasian and African descent HIV-infected populations in Central Europe.Infect Dis Rep. 2017 Oct 2;9(3):7265. doi: 10.4081/idr.2017.7265. eCollection 2017 Oct 2. Infect Dis Rep. 2017. PMID: 29071047 Free PMC article.
References
-
- World Health Organization. HIV/AIDS. Available at: http://www.who.int/hiv/data/en/ (Accessed 23 November 2014).
-
- Carr A, Miller J, Eisman JA, Cooper DA. Osteopenia in HIV-infected men: association with asymptomatic lactic acidaemia and lower weight pre-antiretroviral therapy. AIDS 2001;15:703–709. - PubMed
-
- Knobel H, Guelar A, Vallecillo G, Nogués X, Díez A. Osteopenia in HIV-infected patients: is it the disease or is it the treatment? AIDS 2001;15:807–808. - PubMed
-
- Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J. Decreased bone mineral density in HIV infected patients is independent of retroviral therapy. AIDS 2003;17:1917–1923. - PubMed
-
- Teichmann J, Stephan E, Lange U, Discher T, Friese G, Lohmeyer J et al.. Osteopenia in HIV-infected women prior to highly active antiretroviral therapy. J Infect 2003;46:221–227. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous